Key result
Early intensification of antihypertensive therapy to a fixed triple combination (Triplixam) achieved blood pressure control and target organ protection in a 42-year-old patient.
Why the study?
Early initiation and intensification of hypertension treatment is important to prevent target organ damage, especially in younger patients facing long-term adverse cardiovascular risks.
Does early intensification to a single-pill triple combination of perindopril, indapamide, and amlodipine improve blood pressure control and prevent target organ damage in a young hypertensive patient?
Case Report (n=1)
Does early intensification to a single-pill triple combination of perindopril, indapamide, and amlodipine improve blood pressure control and prevent target organ damage in a young hypertensive patient?
Early initiation and intensification of antihypertensive therapy, such as a single-pill triple combination, is crucial for preventing target organ damage in young hypertensive patients.
Supports early triple-combination use in select young hypertensives; leaves open need for RCTs to confirm target organ protection.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Helena Sládková (2022) conducted a case report in Arterial hypertension with target organ damage (n=1). Triplixam (perindopril, indapamide, amlodipine) vs. Antihypertensive monotherapy and dual combination was evaluated on Blood pressure compensation and target organ protection. Early intensification of antihypertensive therapy to a fixed triple combination (Triplixam) achieved blood pressure control and target organ protection in a 42-year-old patient.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: